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Abstract
Objective: The objective of the present study is to investigate the association between attention-
deficit/hyperactivity disorder (ADHD), predominantly inattentive type (ADHD-I) and prenatal, 
delivery and early postnatal complications (PDPC). Method: In a case-control design, we assessed 
a sample of 124 children and adolescents with ADHD-I and 124 non-ADHD controls (6-17 years old) 
from both a non-referred (n = 200) and a clinical sample (n = 48). Cases and controls, matched by 
gender and age, were systematically evaluated through structured diagnostic interviews. Prenatal, 
delivery and early postnatal complications (PDPC), as well as potential confounders were evaluated 
by direct interview with biological mothers. Results: Conditional logistic regression analysis showed 
that children and adolescents whose mothers presented more PDPC had a significantly higher 
risk for ADHD-I (p = 0.005; OR = 1.25; CI 95%: 1.1-1.5). Conclusions: In a case-control study, we 
expanded to ADHD-I previous findings suggesting the association between perinatal factors and 
broadly defined ADHD. Due to the preventable nature of some of these PDPC, our results have 
clear impact in public mental health policies.
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Existe alguma associação entre complicações perinatais e transtorno de déficit de 
atenção/hiperatividade – subtipo desatento em crianças e adolescentes?
Resumo
Objetivo: O objetivo desse estudo é investigar a associação entre complicações perinatais 
(complicações ocorridas nos períodos pré, peri e pós-natal imediato - CPPs) e transtorno de 
déficit de atenção/hiperatividade (TDAH) do subtipo desatento (TDAH-D). Método: Em um estudo 
de casos e controles, foram avaliadas 124 crianças e adolescentes (6-17 anos) com TDAH-D 
e 124 controles sem a doença, provenientes tanto de uma amostra populacional (n = 200), 
quanto de uma amostra clínica (n = 48). Casos e controles, pareados por gênero e idade, foram 
sistematicamente avaliados através de entrevistas diagnósticas estruturadas. Informações sobre 
as complicações ocorridas durante os períodos pré, peri e pós-natal imediato (CPPs), assim como 
sobre potencias confundidores, foram obtidas através de entrevistas realizadas diretamente com 
as mães biológicas. Resultados: A análise de regressão logística condicional mostrou que para 
as crianças e adolescentes cujas mães apresentaram maior número de CPPs, o risco de TDAH-D 
foi significativamente mais elevado (p = 0.005; OR = 1.25; IC 95%: 1.1-1.5). Conclusões: Em um 
estudo de caso-controle, foi possível expandir, para o TDAH predominantemente desatento, os 
achados prévios que sugeriam a associação entre complicações perinatais e TDAH sem um subtipo 
específico. Em virtude da possibilidade de prevenção de algumas dessas complicações, nossos 
resultados podem exercer impacto sobre políticas públicas de saúde.
DESCRITORES:




Complicações no período 




Although the etiology of ADHD is not entirely clear, studies 
have shown the contribution of genetic and environmental 
factors.1 Results from twin and adoption studies have shown 
that ADHD heritability is high, accounting for more than 
75% of the phenotypic heterogeneity of the disorder.2,3 It is 
important to notice that a high heritability indicates that 
genetic factors account for a large amount of the variation 
in the susceptibility for showing a particular character-
istic in a specific population at a certain point in time. A 
modification of the heritability is to be expected if there are 
changes in genetic or environmental conditions.3 Therefore, 
environmental factors such as prenatal, delivery and early 
postnatal complications (PDPC) may increase the risk of ADHD 
or contribute to its expression.4-6
A large body of literature documents the association of 
complications in pregnancy, delivery, and early neonatal 
period with an increased risk of neurological and psychiatric 
disorders in childhood and adult life.7,8 The central nervous 
system (CNS) is vulnerable to different injuries throughout 
fetal, neonatal and infancy periods. Most frequently, injuries 
to the developing CNS do not result in malformations but 
rather in functional abnormalities detectable only later in 
life (see Huizink & Mulder, 2006, for a review).9 
Case-control studies indicate that pregnancy, labor/de-
livery and early neonatal complications are environmental 
factors found more often in children diagnosed with ADHD 
compared with non-affected controls.5,6,10 Milberger et al.11 
evaluated the role of pregnancy, delivery, and infancy com-
plications (PDIC) in boys with ADHD (n = 140) compared with 
normal controls (n = 120) and with their first-degree biological 
relatives. A positive association between ADHD and PDIC was 
found in this study. Specific complications reflecting chronic 
exposure - such as family problems, maternal bleeding and/
or smoking, and illicit drug use during pregnancy - accounted 
for this result.11 On the other hand, some studies did not find 
significant differences in the occurrence of perinatal compli-
cations comparing ADHD cases and non-affected controls.12,13
Methodological limitations in studies may explain part 
of the contradictory findings. Limitations such as different 
diagnostic criteria to identify affected subjects; use of dif-
ferent instruments to measure PDPC; insufficient adjustment 
for confounding factors - including assessment of familial 
ADHD - and assessment of samples with extreme phenotypic 
variability are some examples.
Reducing phenotypic heterogeneity through the assess-
ment of a more homogeneous group of patients might be an 
interesting strategy for studies assessing the role of either 
genetic or environmental risk factors in ADHD. Several 
Investigators suggest significant clinical differences among 
ADHD types.14 While the combined type (ADHD-C) is the 
most common subtype of ADHD in clinical referred samples, 
the inattentive type (ADHD-I) seems to be more prevalent 
in population-based samples. A recent review showed that 
the predominantly inattentive type was the most common 
ADHD type (45%), followed by ADHD-C (34%) and ADHD-HI 
(21%) in non-referred samples.15 Despite the extensive body 
of literature documenting differences among ADHD types, we 
could not find many studies addressing the role of perinatal 
complications on specific ADHD subtypes.16,17 For instance, 
Langley et al.,16 in a clinical sample of children with ADHD 
and associated antisocial behavior, observed that maternal 
smoking during pregnancy and social class independently 
predict severity of hyperactive-impulsive symptoms and 
conduct disorder. Conversely, the indicators of environ-
mental risk studied (low birth weight, maternal smoking in 
pregnancy and social class) did not predict total number of 
inattentive symptoms. One limitation of this study was the 
modest number of individuals with DSM-IV ADHD predomi-
nantly inattentive type: 19 subjects.16
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Since we are not aware of previous studies investigating 
perinatal risk factors in this specific and highly prevalent 
population of inattentive children, the objective of the 
present study was to examine the role of PDPC in ADHD-I, 
comparing a sample of affected children and adolescents 
with a sample of unaffected controls. Our hypothesis is that 
a higher prevalence of complications during pregnancy, 
delivery, and immediate postnatal period would be found in 
mothers of patients with ADHD-I.
Method
Subjects
The sample for this study was derived from two different 
sources: a) a population-based case-control study [49]; and 
b) the ADHD outpatient program at our University Hospital. 
The inclusion criteria for both samples were (1) age 6 
to 17 years; (2) contact with the biological mother; and (3) 
met full DSM-IV (Diagnostic and Statistical Manual of Mental 
Disorders, 4th edition) diagnostic criteria for ADHD-I. Each 
positive case selected was matched with a control (same 
gender and age). The exclusion criteria for cases and controls 
were an estimated IQ < 70 and the diagnosis of psychosis.
The detailed description of the sampling process for 
subjects enrolled from the population case-control study is 
found elsewhere.18 Briefly, the sample of 100 ADHD-I cases 
and 100 non-affected controls, matched by age and gender, 
was ascertained from 12 public schools in Porto Alegre, Brazil. 
All subjects went through an extensive clinical evaluation in 
our ADHD outpatient clinic.
Regarding the clinical sample, we first selected all ADHD-I 
cases assessed from January 2001 to November 2007 in our 
program that fulfilled the inclusion/exclusion criteria men-
tioned above. Those who could be matched for gender and 
age to a non-ADHD control either assessed in our outpatient 
program or in our general pediatric clinic were invited to 
take part of the study. We identified 51 ADHD-I cases and 41 
potential controls aged 6-17 years old at the time of ascer-
tainment. Four patients with mental retardation (3 cases 
and 1 control) and three cases that did not have contact 
with their biological mothers were excluded. We could not 
find five of the ADHD-I patients and eight of the potential 
controls. From the remaining 72 subjects, 24 ADHD-I cases 
and 24 non-ADHD controls matched for gender and age and 
were included in the study. 
The project was approved by the Ethical Committee of 
our university hospital (approved as an institutional review 
board by the Office for Human Research Protections, United 
States of America, IRB 00000921). Written informed consent 
was obtained from parents for the assessment of children. 
Children or adolescents provided verbal assent to participate 
in the study.
Diagnostic Process
The diagnoses of ADHD-I and its comorbidities were per-
formed in our outpatient clinic through a three-stage process 
described extensively in previous investigations.14,19 First, all 
subjects passed through an initial assessment made with a 
semi-structured interview (Schedule for Affective Disorders 
and Schizophrenia for School-Age Children, Epidemiological 
Version – K-SADS-E)20 modified to assess DSM-IV criteria and 
administered to the parents by trained research assistants. 
This interview had been previously translated into Portuguese 
and the inter-rater reliability for the ADHD diagnosis was 
previously assessed (kappa coefficient = 0.94; p < 0.001).21 
Second, each diagnosis derived from the K-SADS-E was dis-
cussed in a clinical committee chaired by an experienced 
child and adolescent psychiatrist (L.A.R). At the third stage, 
a clinical evaluation of ADHD-I and comorbid conditions were 
performed according to DSM-IV criteria by a child and ado-
lescent psychiatrist who previously had access to K-SADS-E 
results. All diagnostic interviews were conducted with the 
parents and the child or adolescent. When a diagnostic 
disagreement occurred in the three-stage process, priority 
was given to diagnoses derived from clinical interviews.19 
The same diagnostic procedures were applied for the sample 
derived from the case-control study (for details see Schmitz 
et al.18). However, to rest assured that we were dealing with 
a relatively pure ADHD-inattentive type, we only included 
cases fulfilling DSM-IV criteria for ADHD-inattentive type but 
presenting at most three symptoms of hyperactivity/impulsiv-
ity after this extensive evaluation in the non-referred sample. 
In the clinical sample, only cases fulfilling DSM-IV criteria for 
ADHD-I while presenting a maximum final score of one/three 
(range: 0-3) in the hyperactivity/impulsivity subscale of the 
4th revision of the Swanson, Nolan, and Pelham Questionnaire 
(SNAP-IV) were included in the study.22 
The estimated IQ score was obtained from the Vocabulary 
and Block Design subtests of the Wechsler Intelligence Scale-
Third Edition (WISC III) administered by trained psychologists 
in both samples.23
Assessment of Demographic Variables, Pre-, 
Peri-, and Early Postnatal Complications, and 
Potential Confounding Factors
Demographic variables (age, gender, ethnicity, and schooling) 
were assessed with parents. A socioeconomic scale developed 
by the Brazilian Association of Market Research Institutes was 
used to define the families’ socioeconomic status (SES).24 
Children’s and adolescents’ comorbidities were investigated 
through the diagnostic procedures described above. Maternal 
ADHD diagnoses were evaluated by a psychiatrist using the 
ADHD module from the K-SADS-E modified to assess DSM-IV 
criteria as extensively described by other authors.25 This 
investigation was performed by direct clinical interviews in 
the sample from the community and by phone interviews in 
the clinical sample.
We assessed PDPC using a list of potential problems based 
in an extensive review of the available scales used in previous 
studies. First, prenatal, obstetric and neonatal risk factors 
were transformed in dichotomous variables (yes/no) based 
in the cut-points set in these scales.26-30 Second, to increase 
power, we obtained a continuous score based on the sum 
of the complications investigated. This procedure assured 
us a comprehensive inclusion of potential risk variables. 
Pre-, peri-, and early postnatal complications and possible 
confounding factors were assessed by direct interview with 
biological mothers and supplemented with medical records 
when possible. For the clinical sample, mothers were inter-
viewed by telephone.
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Since the role of smoking during pregnancy as a risk fac-
tor for ADHD is already well documented in the literature5,16 
and we previously extended this association for ADHD-I,17 we 
are here interested to assess impact of other PDPC. For this 
reason, smoking during pregnancy was treated as a poten-
tial confounding variable in the present study and was not 
integrated into our total score of PDPC. 
Data Analyses
First, we compared patients with ADHD-I to their non-
ADHD controls regarding age, gender, ethnicity, schooling, 
SES, IQ, maternal ADHD, tobacco use during pregnancy, 
and comorbidities. Second, we defined potential con-
founding factors. They were defined based on conceptual 
analyses of the literature and/or using a broad statistical 
definition (association with both the study factor and 
outcome for a p ≤ 0.20). This approach ensured conser-
vative analyses.
Because each set of a case and a control were matched 
by age and gender, we assessed differences between cases 
and controls for PDPC adjusting for potential confounders 
using conditional logistic regression analysis.31 Analyses 
were performed using the Statistical Package for the Social 
Sciences for Windows, version 13.0 (SPSS). The a level for 
statistical significance was set at p ≤ 0.05. 
Results
First, we compared our clinical and non-referred samples 
regarding the following variables: age, gender, ethnicity, 
schooling, SES, estimate IQ, maternal ADHD diagnosis, smok-
ing during pregnancy and comorbidities. Since no significant 
difference emerged from all comparisons, findings from both 
samples were distributed in two categories – ADHD-I and 
controls – for all further analyses. Demographic and clini-
cal characteristics of the 124 ADHD-I subjects and the 124 
non-ADHD controls are shown in Table 1. Compared with the 
control group, the ADHD-I group presented more maternal 
ADHD diagnoses (p < 0.001), lower estimated IQ (p = 0.001), 
higher number of cigarettes smoked per day during pregnancy 
(p = 0.017), and greater social phobia (p < 0.001) and op-
positional defiant disorder (p < 0.001).
Pre-, peri-, and postnatal variables assessed are described 
in Table 2, along with the prevalence of each variable for 
cases and controls. A significant difference was found in the 
average number of complications (p = 0.002). Regarding 
specific variables, differences were detected in the number 
of previous pregnancies (p = 0.008), and previous abortions 
(p = 0.009). Mothers of ADHD-I children also presented 
more illnesses (p = 0.003) and used more prescribed drugs 
(p = 0.003) during pregnancy, compared with mothers of 
non-affected controls.  
Table 1 Demographic and clinical characteristics of ADHD-I cases and non-affected controls
Characteristic ADHD-I (n = 124) Controls (n = 124) p-value
Average age, months (SD) 141.7 (38) 140 (37) 0.7
Gender: n (%) male 86 (69.4) 86 (69.4) 1
Ethnicity: n (%) white 83 (67) 91 (73) 0.33
Average schooling, years (SD) 4.4 (2.7) 4.6 (3) 0.6
SES: middle class (%) 70 (58) 72 (59) 0.89
Average estimate IQ (SD) 93.5 (12.4) 98.8 (11.5) 0.001
Maternal ADHD: no. (%) 29 (23.6) 5 (4) < 0.001
Average of cigarettes/day: median (range) 0 (0 to 40) 0 (0 to 20) 0.017
Children and adolescents comorbidities: 
Mood disorders
Major depression 5 (4) 3 (2.4) 0.72
Dysthymia 5 (4) 1 (.8) 0.21
Anxiety disorders
Simple phobia 24 (19.4) 25 (20.2) 1
GAD 15 (12) 6 (4.8) 0.06
SAD 9 (7.3) 7 (5.6) 0.8
Social phobia 23 (18.5) 5 (4) < 0.001
Agoraphobia 13 (10.5) 6 (4.8) 0.15
Disruptive behavior disorders
ODD 45 (36.3) 19 (15.3) < 0.001
CD 3 (2.4) 1 (.8) 0.62
ADHD-I: attention deficit/hyperactivity disorder - inattentive type; SD: standard deviation; SES: socioeconomic status; GAD: generalized anxiety disorder; 
SAD: separation anxiety disorder; ODD: oppositional defiant disorder; CD: conduct disorder.
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The diagnoses of oppositional defiant disorder (ODD), 
generalized anxiety disorder (GAD), and agoraphobia were 
considered potential confounding factors (associations for 
both the study factor and the outcome measure with p ≤ 0.2). 
We decided to conservatively keep in the model maternal 
ADHD and number of cigarettes smoked per day during preg-
nancy based on conceptual analyses of literature.
The conditional logistic regression analysis (adjusted for 
these five confounding factors) demonstrated that children 
and adolescents whose mothers presented more PDPC had 
a significant higher risk for ADHD-I (p = 0.005; OR = 1.25; CI 
95% 1.1-1.5) (Table 3). 
Discussion
We investigated the association between pre-, peri-, and 
early postnatal complications and the diagnosis of ADHD-I in 
a sample with 248 children and adolescents. We were able 
to find significant differences between cases and controls 
regarding to the presence of these complications. An increase 
in the number of PDPC determined a higher OR for ADHD-I. 
The strength of the association found between PDPC 
and ADHD-I may have been small and more significant in the 
clinical sample. This is expected since population and clini-
cal samples can have different abilities to detect association 
with causal factors. This can be a limitation of our study.
These findings suggest that biological risk factors, such 
as PDPC, may play an important role in the pathogenesis 
of ADHD-I regardless the presence of comorbid disorders in 
probands, ADHD diagnosis in mothers, and tobacco exposure 
during pregnancy. The combination of multiple environ-
mental factors as risk factors for ADHD is an interesting 
direction for future investigation of the dopamine deficit 
hypothesis of ADHD. In animal models, the dopaminergic 
system appears to be particularly vulnerable to a wide 
range of perinatal insults, resulting in persistent alterations 
in function of mesolimbic and mesostriatal pathways (see 
Boksa & El-Khodor, 2003, for a review).7 In a recent study, 
adult rats that were exposed to repeated hypoxia during 
the equivalent of extreme prematurity were hyperactive 
in response to delayed reward.32 
Table 2 Odds ratio (OR) for ADHD-I according to perinatal complications, adjusted for potential confounders
Complications SE Wald p-value Adjusted OR 95%CI
Prenatal
Maternal age during pregnancy < 16 or > 34 years-old 0.4 0.1 0.7 1.1a 0.5-2
More than 4 previous pregnancies 1.3 1 0.3 3.7b 0.3-49
Previous abortion 0.4 1.5 0.2 1.6c 0.7-3
Bleeding during pregnancy 0.5 0.8 0.4 1.5d 0.6-4
Rhesus incompatibility 0.6 0.5 0.5 0.6e 0.2-2
Maternal illness during pregnancy 0.4 7 0.01 2.7f 1.3-6
Use of prescribed drugs 0.5 8.5 0.003 4.6g 1.6-13
Alcohol use during pregnancy 0.7 3 0.1 3.2h 0.8-12.6
Drug use during pregnancy 2 0.6 0.4 0.3i 0.01-8
Perinatal
Caesarian delivery 0.3 1 0.3 1.3j 0.8-2
Bad fetal position (breech or transverse) 1 1.5 0.2 0.4k 0.1-2
Anesthesia 0.3 0.04 0.8 1l 0.6-2
Preeclampsia / eclampsia 0.4 0.7 0.4 1.5m 0.6-3.5
Placental abnormalities 1 2 0.1 4n 0.6-21
Early Postnatal
Low birth weight (< 2,500 g) 0.6 0.1 0.7 1o 0.3-3
Prematurity 0.4 1 0.3 1.5p 0.7-3.5
Neonatal jaundice 0.4 0.005 1 1q 0.4-2
Cord around neck 1 0.01 1 1r 0.1-5.5
Acute postnatal complications 0.6 0.2 0.7 1s 0.4-4.5
ADHD-I:  attention deficit/hyperactivity disorder – predominantly inattentive subtype;
CI: confidence interval; CDP: cigarettes/day during pregnancy; GAD: generalized anxiety disorder; ODD: oppositional defiant disorder;  SE: standard error; SP: 
social phobia;  y.o: years old;  a: adjusted for IQ, maternal ADHD and CDP;  b: adjusted for IQ, maternal ADHD and CDP;   c: adjusted for SP, agoraphobia, ODD, 
maternal ADHD and CDP;  d: adjusted for IQ, SP, agoraphobia, maternal ADHD and CDP;  e: adjusted for  maternal ADHD and CDP;  f: adjusted for agoraphobia, 
ODD, maternal ADHD and CDP;  g: adjusted for GAD, ODD, maternal ADHD and CDP;  h: adjusted for IQ, SP, ODD, maternal ADHD and CDP;
 i: adjusted for  maternal ADHD and CDP;  j: adjusted for IQ, maternal ADHD and CDP;  k:adjusted for maternal ADHD and CDP;  l: adjusted for SP, agoraphobia, 
maternal ADHD and CDP;  m: adjusted for  agoraphobia,  maternal ADHD and CDP;  n: adjusted for  agoraphobia,  maternal ADHD and CDP;  o: adjusted for 
GAD, agoraphobia,  ODD, maternal ADHD and CDP;  p: adjusted for GAD, agoraphobia, ODD, maternal ADHD and CDP;  q: adjusted GAD, maternal ADHD and 
CDP;  r: adjusted for IQ, GAD, maternal ADHD and CDP;  s: adjusted for IQ, GAD, agoraphobia,  maternal ADHD and CDP.  
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There is no doubt that severe perinatal adversity can 
damage the CNS development. This will apply, for instance, 
to cerebral palsy, intraventricular hemorrhage, or when birth 
weight is less than 1,500 g or the gestational age is less than 
29 weeks. Milder levels of perinatal stress are much more 
common, and may be significant if they occur in combina-
tion.8 In fact, a large number of epidemiological studies 
confirmed that obstetric complications associated with fetal 
or neonatal hypoxia increase the risk for schizophrenia.33,34 
Also, Kinney et al.27 found association between obstetric 
complications and bipolar disorders.27
The association between PDPC and ADHD-I suggested in 
our study concurs with those found in the existing literature 
for ADHD in general. There is an increasing interest on the 
study of the association of pregnancy and delivery complica-
tions and ADHD in the last few years, with most of the studies 
showing positive results for this association.2,35 For example, 
Amor et al.35 found greater number of neonatal complications 
in their sample of 50 ADHD children compared with their 
50 unaffected siblings. No differences between cases and 
controls related to low birth and to maternal alcohol and 
tobacco consumption during pregnancy were found.35 In an-
other study, disruptive behavior disorders were significantly 
associated with maternal physical problems during pregnancy 
and delivery, especially acute anoxia/hypoxia.26 However, 
there is a scarcity of studies addressing the association be-
tween inattentive scores and perinatal risk factors. Previous 
investigations have suggested that both environmental and 
genetic factors contribute to the phenotypic heterogene-
ity of ADHD characterized by the type and severity of the 
symptoms (ADHD subtypes).16 
Our findings must be understood in the context of some 
limitations. First, our measurement of exposure was suscep-
tible to error since retrospective case-control studies rely 
on self-report interviews. However, to check the reliability 
of our estimates of association, we compared mothers’ 
information to hospital registers in 38% of our sample. For 
example, the mean difference between mother’s information 
and hospital registers in birth weight was 7 g (p = 0.8). No 
other significant difference emerged from these comparisons. 
Second, mothers can underreport perinatal complications 
which might have affected our results in a conservative 
way.36,37 Cantor-Graae et al.38 found no significant differ-
ences between patient and control mothers in error type 
or recall facility for selected events. However, patients had 
significantly more obstetric events than controls only when 
hospital record information was utilized.38 
As we know, the contribution of genetic factors in ADHD 
heritability is very high: around 75%.2,3 So, we expected to 
find a significant association between diagnosis of maternal 
ADHD and ADHD-I in the probands (Table 3). This also can be 
a limitation of our study that we tried to reduce including 
maternal ADHD as a confounding factor (for both cases and 
controls) in our analyses. 
A recent study about the association between smoking 
in pregnancy and ADHD showed evidence that this associa-
tion could be confounded by genetic variants. The authors 
evaluated the association between antenatal smoking and 
ADHD behavior in the offspring in mothers genetically related 
(normal in vitro fertilization) and genetically unrelated (in 
vitro fertilization with egg donation). Association between 
smoking during pregnancy and lower birth weight was found 
in unrelated and related mother-offspring pairs. However, 
for ADHD symptoms, the magnitude of association was sig-
nificantly higher in the related pairs (p < 0.02) than in the 
unrelated pairs (p > 0.10), suggesting inherited effects. One 
major problem was the small sample size of the unrelated 
group genetic who smoked (n = 9).39 Other recent studies 
have been showing the association between intrauterine 
tobacco exposure and low birth weight, prematurity and 
intrauterine growth restriction.40-42 Even though we chose to 
include the number of cigarettes/day during pregnancy as 
a potential confounding factor in the analyses because this 
variable was associated with ADHD-I in the study by Schmitz 
et al that used a similar sample.17 
Finally, we assessed some variables from direct interviews 
in the community sample and from phone interviews in the 
clinical sample. Although this might create noise in analy-
ses, we were not able to identify any significant difference 
between clinical and community samples in these variables.
Our strategy for measuring PDPC was not based in the 
application of any individual scale. Most of the studies have 
been using scales created in the early seventies to identify 
pre- and perinatal complications in mothers of schizophrenic 
patients. The scales generate scores considering different 
weights for complications based on levels of severity. Since 
we were not able to identify any study testing the validity 
of these scores, we implemented a more comprehensive 
Table 3 Odds ratio (OR) for ADHD-I according to perinatal complications, adjusted for potential confounders in ADHD-I 
cases and controls
SE Wald p value Unadjusted OR Adjusted OR 95%CI
Perinatal complications 0.08 7.6 0.005 1.23 1.25 1.1-1.5
GAD 0.63 0 0.9 2.5 1 0.3-3.5
Agoraphobia 0.6 2.6 0.1 2.16 2.6 0.8-8.6
ODD 0.36 3.8 0.05 2.85 2 1.0-4.2
Maternal ADHD 0.6 11 0.001 7 11 2.2-23.2
Cigarettes/day during pregnancy 0.03 1.7 0.2 1.06 1 0.9-1.1
ADHD-I: attention deficit/hyperactivity disorder – predominantly inattentive subtype; CI: confidence interval; GAD: generalized anxiety disorder;  
ODD: oppositional defiant disorder; SE: standard error.
327Perinatal risk factors and ADHD-inattentive type
strategy of including the entire list of variables from different 
scales.5,11,26-30,35 Despite the lack of studies on the validity of 
these scales, we decided to check our results entering data 
to generate scores in the extensively used scale developed 
by Kinney et al.27 Using this analytic strategy, the conditional 
logistic regression analysis (adjusted for the same five con-
founding factors) showed very similar results (p = 0.007; 
OR = 1.2; CI 95% 1.05-1.35).
A recent revision paper considered prenatal, perinatal 
and postnatal factors together as acquired risk factors in the 
etiology of ADHD. The author suggested that environmental 
factors, including prematurity, alcohol and tobacco exposure 
during pregnancy, cerebral hypoxic ischemia, viral infection 
and endocrine disorders may contribute as secondary causes 
for ADHD. He also emphasized that the early prenatal recogni-
tion, prevention, and treatment of environmental causes may 
provide more effective management and reduces the reliance 
on symptom modification with medication. Furthermore, 
advice regarding hazards of nicotine and alcohol exposure 
and monitoring of blood count and thyroid function during 
pregnancy could be particularly important for patients with 
a family history of ADHD.43 
Conclusion
There is an extensive debate in the literature on the valid-
ity of ADHD subtypes in the DSM-V era.44 Moreover, it is not 
clear if “real” ADHD predominantly inattentive type (not 
only subthreshold ADHD combined) is a different nosologi-
cal construct than the well established ADHD-combined 
construct. Our findings corroborate for this discussion 
showed that similar environmental factors may act as 
environmental triggers in both conditions. Another inter-
esting strategy for future studies is to evaluate the role 
of perinatal factors between ADHD-I and ADHD-combined 
samples.
In a recent review of community-based interventions 
for improving perinatal and neonatal health outcomes in 
developing countries, authors emphasized the lack of stud-
ies addressing the impact of “standardized” antenatal care 
programs on maternal health and pregnancy outcomes.45 
Even in this context, our results can have a clear impact in 
public mental health policies due to the preventable nature 
of some of these PDPC.
In sum, our results suggest that there is an association 
between ADHD-I and perinatal complications. As far as we 
are aware, this study is the first to focus on a sample of 
extensively assessed subjects with ADHD – predominantly 
inattentive type. Our results expanded to ADHD-I previous 
findings suggesting the association between perinatal fac-
tors and broadly defined ADHD in clinical samples. Future 
prospective studies are necessary to establish a causal 
association.
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